Oral versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis
Author:
Publisher
John Wiley & Sons, Ltd
Link
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006921.pub2/epdf/full
Reference41 articles.
1. Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose;Alam;Journal of Neurology, Neurosurgery and Psychiatry,1993
2. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis;Barnes;Lancet,1997
3. Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis;Pitzalis;Journal of Neuroimmunology,1997
4. The effect of oral and intravenous methylprednisolone treatment of subsequent relapse rate in multiple sclerosis;Sharrack;Journal of the Neurological Sciences,2000
5. Martinelli V Pulizzi A Annovazzi P Rocca MA Bucello S Esposito F A single blind, randomised MRI study comparing high-dose oral and intravenous methylprednisolone in treating MS relapses A single blind, randomised MRI study comparing high-dose oral and intravenous methylprednisolone in treating MS relapses Multiple Sclerosis 2008
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates;Multiple Sclerosis and Related Disorders;2024-08
2. Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses;World Journal of Psychiatry;2023-04-19
3. An interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2) - development, feasibility, and pilot testing of a complex intervention;Frontiers in Neurology;2022-09-23
4. Successful treatment with 5-day oral 1 g/day methylprednisolone of optic neuritis and myelitis in AQP4 positive Neuromyelitis Optica: A report of two cases;Neuroimmunology Reports;2021-12
5. Evaluation of an interactive web-based programme on relapse management for people with multiple sclerosis (POWER@MS2): study protocol for a process evaluation accompanying a randomised controlled trial;BMJ Open;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3